Subtype
Lung Non-Squamous Non-Small Cell Carcinoma
CI-CAN-00005826Explore in graph →
- NCIt
- C135017
Loading cancer entity…
Subtype
CI-CAN-00005826Explore in graph →
Genomics
20 cohorts mapped to this entity or its descendants. Each frequency is affected / profiled within one cohort; cohorts are shown separately because case selection, sequencing depth and definitions differ. By default the cohort with the most cases profiled is shown.
87 cases with simple somatic mutation data · 87 cases total · Data Release 46.0 · mapped to Lung Adenocarcinoma ONTOLOGY_EXACT
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|
Cohorts mapped to a descendant (e.g. a subtype) are included because their cases belong to this entity by definition; the mapping and its match type are shown per cohort.
| 1 | HSPA6 | Ssm | 60 | 87 | 69% | gdc |
| 2 | FCGR3A | Ssm | 60 | 87 | 69% | gdc |
| 3 | FCGR3B | Ssm | 59 | 87 | 67.8% | gdc |
| 4 | FCGR2B | Ssm | 59 | 87 | 67.8% | gdc |
| 6 | CREB3L4 | Ssm | 58 | 87 | 66.7% | gdc |
| 5 | TPM3 | Ssm | 58 | 87 | 66.7% | gdc |
| 23 | SLC39A1 | Ssm | 58 | 87 | 66.7% | gdc |
| 22 | AL358472.6 | Ssm | 58 | 87 | 66.7% | gdc |
| 21 | RAB13 | Ssm | 58 | 87 | 66.7% | gdc |
| 20 | RPS27 | Ssm | 58 | 87 | 66.7% | gdc |
| 19 | FCRLB | Ssm | 58 | 87 | 66.7% | gdc |
| 18 | GATAD2B | Ssm | 58 | 87 | 66.7% | gdc |
| 17 | FCRLA | Ssm | 58 | 87 | 66.7% | gdc |
| 16 | SLAMF6 | Ssm | 58 | 87 | 66.7% | gdc |
| 15 | DENND4B | Ssm | 58 | 87 | 66.7% | gdc |
| 14 | AL358472.7 | Ssm | 58 | 87 | 66.7% | gdc |
| 13 | UHMK1 | Ssm | 58 | 87 | 66.7% | gdc |
| 12 | CD84 | Ssm | 58 | 87 | 66.7% | gdc |
| 11 | NUP210L | Ssm | 58 | 87 | 66.7% | gdc |
| 10 | JTB | Ssm | 58 | 87 | 66.7% | gdc |
| 8 | CRTC2 | Ssm | 58 | 87 | 66.7% | gdc |
| 9 | UAP1 | Ssm | 58 | 87 | 66.7% | gdc |
| 7 | FCGR2A | Ssm | 58 | 87 | 66.7% | gdc |
| 30 | KCNJ9 | Ssm | 57 | 87 | 65.5% | gdc |
| 28 | ATF6 | Ssm | 57 | 87 | 65.5% | gdc |
| 27 | EFNA4 | Ssm | 57 | 87 | 65.5% | gdc |
| 26 | C1orf43 | Ssm | 57 | 87 | 65.5% | gdc |
| 25 | MSTO1 | Ssm | 57 | 87 | 65.5% | gdc |
| 24 | AL691442.1 | Ssm | 57 | 87 | 65.5% | gdc |
| 29 | C1orf189 | Ssm | 57 | 87 | 65.5% | gdc |
Data updated 22 days agoSource updated Data Release 46.0
50 cases with simple somatic mutation data · 50 cases total · Data Release 46.0 · mapped to Lung Adenocarcinoma ONTOLOGY_EXACT
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | PRPF3 | Ssm | 35 | 50 | 70% | gdc |
| 2 | SPTA1 | Ssm | 35 | 50 | 70% | gdc |
| 3 | ECM1 | Ssm | 34 | 50 | 68% | gdc |
| 4 | SETDB1 | Ssm | 34 | 50 | 68% | gdc |
| 5 | CA14 | Ssm | 34 | 50 | 68% | gdc |
| 6 | PRUNE1 | Ssm | 34 | 50 | 68% | gdc |
| 7 | ADAMTSL4 | Ssm | 34 | 50 | 68% | gdc |
| 8 | PIP5K1A | Ssm | 34 | 50 | 68% | gdc |
| 9 | MRPS21 | Ssm | 34 | 50 | 68% | gdc |
| 10 | ANP32E | Ssm | 34 | 50 | 68% | gdc |
| 11 | RPRD2 | Ssm | 34 | 50 | 68% | gdc |
| 12 | GBA | Ssm | 34 | 50 | 68% | gdc |
| 13 | TARS2 | Ssm | 34 | 50 | 68% | gdc |
| 14 | C1orf54 | Ssm | 34 | 50 | 68% | gdc |
| 15 | SYT11 | Ssm | 34 | 50 | 68% | gdc |
| 16 | CTXND2 | Ssm | 34 | 50 | 68% | gdc |
| 17 | MTX1 | Ssm | 34 | 50 | 68% | gdc |
| 18 | CIART | Ssm | 34 | 50 | 68% | gdc |
| 19 | TTN | Ssm | 34 | 50 | 68% | gdc |
| 20 | APH1A | Ssm | 34 | 50 | 68% | gdc |
| 21 | CERS2 | Ssm | 34 | 50 | 68% | gdc |
| 22 | MSTO1 | Ssm | 33 | 50 | 66% | gdc |
| 23 | ANXA9 | Ssm | 33 | 50 | 66% | gdc |
| 24 | SCAMP3 | Ssm | 33 | 50 | 66% | gdc |
| 25 | CLK2 | Ssm | 33 | 50 | 66% | gdc |
| 26 | MLLT11 | Ssm | 33 | 50 | 66% | gdc |
| 27 | POGZ | Ssm | 33 | 50 | 66% | gdc |
| 28 | GON4L | Ssm | 33 | 50 | 66% | gdc |
| 29 | SEMA6C | Ssm | 33 | 50 | 66% | gdc |
| 30 | RFX5 | Ssm | 33 | 50 | 66% | gdc |
Data updated 22 days agoSource updated Data Release 46.0
573 cases with simple somatic mutation data · 585 cases total · Data Release 46.0 · mapped to Lung Adenocarcinoma ONTOLOGY_EXACT
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | RYR2 | Ssm | 413 | 573 | 72.1% | gdc |
| 2 | FLG | Ssm | 406 | 573 | 70.9% | gdc |
| 3 | USH2A | Ssm | 402 | 573 | 70.2% | gdc |
| 4 | SPTA1 | Ssm | 400 | 573 | 69.8% | gdc |
| 5 | TP53 | Ssm | 393 | 573 | 68.6% | gdc |
| 6 | FLG2 | Ssm | 388 | 573 | 67.7% | gdc |
| 8 | HRNR | Ssm | 383 | 573 | 66.8% | gdc |
| 7 | CSMD3 | Ssm | 383 | 573 | 66.8% | gdc |
| 9 | TNR | Ssm | 382 | 573 | 66.7% | gdc |
| 11 | ASH1L | Ssm | 382 | 573 | 66.7% | gdc |
| 10 | TNN | Ssm | 382 | 573 | 66.7% | gdc |
| 12 | HMCN1 | Ssm | 379 | 573 | 66.1% | gdc |
| 13 | MUC16 | Ssm | 376 | 573 | 65.6% | gdc |
| 15 | TCHH | Ssm | 374 | 573 | 65.3% | gdc |
| 14 | CACNA1E | Ssm | 374 | 573 | 65.3% | gdc |
| 16 | PAPPA2 | Ssm | 374 | 573 | 65.3% | gdc |
| 17 | ASTN1 | Ssm | 373 | 573 | 65.1% | gdc |
| 18 | KCNN3 | Ssm | 372 | 573 | 64.9% | gdc |
| 20 | ASPM | Ssm | 371 | 573 | 64.7% | gdc |
| 19 | NUP210L | Ssm | 371 | 573 | 64.7% | gdc |
| 23 | FCRL5 | Ssm | 370 | 573 | 64.6% | gdc |
| 22 | ADAR | Ssm | 370 | 573 | 64.6% | gdc |
| 21 | ATP8B2 | Ssm | 370 | 573 | 64.6% | gdc |
| 25 | AQP10 | Ssm | 369 | 573 | 64.4% | gdc |
| 26 | PKLR | Ssm | 369 | 573 | 64.4% | gdc |
| 24 | NPR1 | Ssm | 369 | 573 | 64.4% | gdc |
| 29 | SETDB1 | Ssm | 368 | 573 | 64.2% | gdc |
| 27 | CLK2 | Ssm | 368 | 573 | 64.2% | gdc |
| 30 | SEMA6C | Ssm | 368 | 573 | 64.2% | gdc |
| 28 | PEAR1 | Ssm | 368 | 573 | 64.2% | gdc |
Data updated 22 days agoSource updated Data Release 46.0
183 cases with simple somatic mutation data · 183 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 95 | 183 | 51.9% | cbioportal |
| 2 | TTN | Ssm | 83 | 183 | 45.4% | cbioportal |
| 3 | MUC16 | Ssm | 71 | 183 | 38.8% | cbioportal |
| 4 | USH2A | Ssm | 64 | 183 | 35% | cbioportal |
| 5 | CSMD3 | Ssm | 62 | 183 | 33.9% | cbioportal |
| 6 | RYR2 | Ssm | 62 | 183 | 33.9% | cbioportal |
| 7 | LRP1B | Ssm | 59 | 183 | 32.2% | cbioportal |
| 8 | SPTA1 | Ssm | 56 | 183 | 30.6% | cbioportal |
| 9 | KRAS | Ssm | 49 | 183 | 26.8% | cbioportal |
| 10 | XIRP2 | Ssm | 49 | 183 | 26.8% | cbioportal |
| 11 | ZFHX4 | Ssm | 49 | 183 | 26.8% | cbioportal |
| 12 | FAT3 | Ssm | 48 | 183 | 26.2% | cbioportal |
| 13 | FLG | Ssm | 48 | 183 | 26.2% | cbioportal |
| 14 | PCLO | Ssm | 43 | 183 | 23.5% | cbioportal |
| 15 | PCDH15 | Ssm | 40 | 183 | 21.9% | cbioportal |
| 16 | OBSCN | Ssm | 37 | 183 | 20.2% | cbioportal |
| 19 | CSMD1 | Ssm | 35 | 183 | 19.1% | cbioportal |
| 17 | ABCA13 | Ssm | 35 | 183 | 19.1% | cbioportal |
| 18 | APOB | Ssm | 35 | 183 | 19.1% | cbioportal |
| 20 | MUC17 | Ssm | 35 | 183 | 19.1% | cbioportal |
| 21 | PAPPA2 | Ssm | 35 | 183 | 19.1% | cbioportal |
| 22 | RYR3 | Ssm | 35 | 183 | 19.1% | cbioportal |
| 23 | SI | Ssm | 35 | 183 | 19.1% | cbioportal |
| 24 | NRXN1 | Ssm | 34 | 183 | 18.6% | cbioportal |
| 25 | COL11A1 | Ssm | 32 | 183 | 17.5% | cbioportal |
| 26 | EGFR | Ssm | 32 | 183 | 17.5% | cbioportal |
| 27 | RELN | Ssm | 32 | 183 | 17.5% | cbioportal |
| 28 | RP1L1 | Ssm | 32 | 183 | 17.5% | cbioportal |
| 29 | ADGRL3 | Ssm | 31 | 183 | 16.9% | cbioportal |
| 30 | DNAH9 | Ssm | 31 | 183 | 16.9% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
103 cases with simple somatic mutation data · 103 cases total · 2026-01-19 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 53 | 103 | 51.5% | cbioportal |
| 2 | EGFR | Ssm | 51 | 103 | 49.5% | cbioportal |
| 3 | TTN | Ssm | 23 | 103 | 22.3% | cbioportal |
| 4 | RYR2 | Ssm | 15 | 103 | 14.6% | cbioportal |
| 5 | MUC16 | Ssm | 13 | 103 | 12.6% | cbioportal |
| 6 | AHNAK2 | Ssm | 12 | 103 | 11.7% | cbioportal |
| 7 | MUC17 | Ssm | 12 | 103 | 11.7% | cbioportal |
| 8 | OBSCN | Ssm | 12 | 103 | 11.7% | cbioportal |
| 9 | ZNF536 | Ssm | 11 | 103 | 10.7% | cbioportal |
| 10 | APOB | Ssm | 10 | 103 | 9.7% | cbioportal |
| 11 | CSMD3 | Ssm | 10 | 103 | 9.7% | cbioportal |
| 12 | FLG | Ssm | 10 | 103 | 9.7% | cbioportal |
| 13 | HMCN1 | Ssm | 10 | 103 | 9.7% | cbioportal |
| 14 | COL11A1 | Ssm | 9 | 103 | 8.7% | cbioportal |
| 15 | DMD | Ssm | 9 | 103 | 8.7% | cbioportal |
| 16 | FAT3 | Ssm | 9 | 103 | 8.7% | cbioportal |
| 17 | MUC12 | Ssm | 9 | 103 | 8.7% | cbioportal |
| 18 | PLEC | Ssm | 9 | 103 | 8.7% | cbioportal |
| 19 | RYR1 | Ssm | 9 | 103 | 8.7% | cbioportal |
| 20 | SPEG | Ssm | 9 | 103 | 8.7% | cbioportal |
| 21 | USH2A | Ssm | 9 | 103 | 8.7% | cbioportal |
| 22 | BRINP3 | Ssm | 8 | 103 | 7.8% | cbioportal |
| 23 | EYS | Ssm | 8 | 103 | 7.8% | cbioportal |
| 24 | ICE1 | Ssm | 8 | 103 | 7.8% | cbioportal |
| 25 | MUC5B | Ssm | 8 | 103 | 7.8% | cbioportal |
| 26 | PAPPA2 | Ssm | 8 | 103 | 7.8% | cbioportal |
| 27 | PCDH15 | Ssm | 8 | 103 | 7.8% | cbioportal |
| 28 | RELN | Ssm | 8 | 103 | 7.8% | cbioportal |
| 29 | RYR3 | Ssm | 8 | 103 | 7.8% | cbioportal |
| 30 | TENM4 | Ssm | 8 | 103 | 7.8% | cbioportal |
Data updated 22 days agoSource updated 2026-01-19
110 cases with simple somatic mutation data · 110 cases total · 2026-01-16 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 59 | 110 | 53.6% | cbioportal |
| 2 | EGFR | Ssm | 38 | 110 | 34.5% | cbioportal |
| 3 | MUC16 | Ssm | 37 | 110 | 33.6% | cbioportal |
| 4 | RYR2 | Ssm | 35 | 110 | 31.8% | cbioportal |
| 5 | TTN | Ssm | 35 | 110 | 31.8% | cbioportal |
| 6 | LRP1B | Ssm | 34 | 110 | 30.9% | cbioportal |
| 8 | KRAS | Ssm | 33 | 110 | 30% | cbioportal |
| 7 | CSMD3 | Ssm | 33 | 110 | 30% | cbioportal |
| 9 | USH2A | Ssm | 28 | 110 | 25.5% | cbioportal |
| 10 | ZFHX4 | Ssm | 26 | 110 | 23.6% | cbioportal |
| 11 | FAT3 | Ssm | 23 | 110 | 20.9% | cbioportal |
| 12 | COL11A1 | Ssm | 22 | 110 | 20% | cbioportal |
| 13 | FAM135B | Ssm | 21 | 110 | 19.1% | cbioportal |
| 14 | SPTA1 | Ssm | 21 | 110 | 19.1% | cbioportal |
| 15 | CSMD1 | Ssm | 20 | 110 | 18.2% | cbioportal |
| 16 | PCLO | Ssm | 20 | 110 | 18.2% | cbioportal |
| 17 | STK11 | Ssm | 20 | 110 | 18.2% | cbioportal |
| 18 | APOB | Ssm | 19 | 110 | 17.3% | cbioportal |
| 19 | EYS | Ssm | 19 | 110 | 17.3% | cbioportal |
| 20 | MUC17 | Ssm | 19 | 110 | 17.3% | cbioportal |
| 21 | NRXN1 | Ssm | 19 | 110 | 17.3% | cbioportal |
| 22 | PCDH15 | Ssm | 19 | 110 | 17.3% | cbioportal |
| 23 | CNTNAP2 | Ssm | 18 | 110 | 16.4% | cbioportal |
| 24 | FLG | Ssm | 18 | 110 | 16.4% | cbioportal |
| 25 | XIRP2 | Ssm | 18 | 110 | 16.4% | cbioportal |
| 26 | ADAMTS12 | Ssm | 17 | 110 | 15.5% | cbioportal |
| 27 | ANK2 | Ssm | 17 | 110 | 15.5% | cbioportal |
| 28 | FBN2 | Ssm | 17 | 110 | 15.5% | cbioportal |
| 29 | LRTM3 | Ssm | 17 | 110 | 15.5% | cbioportal |
| 30 | NAV3 | Ssm | 17 | 110 | 15.5% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
236 cases with simple somatic mutation data · 241 cases total · 2026-01-14 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 119 | 236 | 50.4% | cbioportal |
| 2 | RYR2 | Ssm | 80 | 236 | 33.9% | cbioportal |
| 3 | CSMD3 | Ssm | 76 | 236 | 32.2% | cbioportal |
| 4 | MUC16 | Ssm | 75 | 236 | 31.8% | cbioportal |
| 5 | EGFR | Ssm | 70 | 236 | 29.7% | cbioportal |
| 6 | USH2A | Ssm | 70 | 236 | 29.7% | cbioportal |
| 7 | KRAS | Ssm | 69 | 236 | 29.2% | cbioportal |
| 8 | TTN | Ssm | 68 | 236 | 28.8% | cbioportal |
| 9 | ZFHX4 | Ssm | 57 | 236 | 24.2% | cbioportal |
| 10 | LRP1B | Ssm | 53 | 236 | 22.5% | cbioportal |
| 11 | XIRP2 | Ssm | 53 | 236 | 22.5% | cbioportal |
| 12 | CSMD1 | Ssm | 51 | 236 | 21.6% | cbioportal |
| 13 | FSIP2 | Ssm | 51 | 236 | 21.6% | cbioportal |
| 14 | LRTM3 | Ssm | 47 | 236 | 19.9% | cbioportal |
| 15 | SPTA1 | Ssm | 47 | 236 | 19.9% | cbioportal |
| 16 | FAT3 | Ssm | 45 | 236 | 19.1% | cbioportal |
| 17 | EYS | Ssm | 44 | 236 | 18.6% | cbioportal |
| 18 | MUC17 | Ssm | 44 | 236 | 18.6% | cbioportal |
| 19 | PCLO | Ssm | 42 | 236 | 17.8% | cbioportal |
| 20 | APOB | Ssm | 41 | 236 | 17.4% | cbioportal |
| 21 | COL11A1 | Ssm | 41 | 236 | 17.4% | cbioportal |
| 22 | FLG | Ssm | 41 | 236 | 17.4% | cbioportal |
| 23 | SYNE1 | Ssm | 40 | 236 | 16.9% | cbioportal |
| 24 | ZNF536 | Ssm | 40 | 236 | 16.9% | cbioportal |
| 25 | PCDH15 | Ssm | 38 | 236 | 16.1% | cbioportal |
| 26 | FAT4 | Ssm | 37 | 236 | 15.7% | cbioportal |
| 27 | NAV3 | Ssm | 37 | 236 | 15.7% | cbioportal |
| 28 | STK11 | Ssm | 37 | 236 | 15.7% | cbioportal |
| 29 | ANK2 | Ssm | 36 | 236 | 15.3% | cbioportal |
| 30 | RYR3 | Ssm | 36 | 236 | 15.3% | cbioportal |
Data updated 22 days agoSource updated 2026-01-14
2,653 cases with simple somatic mutation data · 2,653 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 1,429 | 2,653 | 53.9% | cbioportal |
| 59 | TTN | Ssm | 90 | 231 | 39% | cbioportal |
| 65 | RYR2 | Ssm | 85 | 231 | 36.8% | cbioportal |
| 2 | EGFR | Ssm | 866 | 2,653 | 32.6% | cbioportal |
| 82 | MUC16 | Ssm | 72 | 231 | 31.2% | cbioportal |
| 3 | KRAS | Ssm | 787 | 2,653 | 29.7% | cbioportal |
| 90 | CSMD3 | Ssm | 65 | 231 | 28.1% | cbioportal |
| 94 | LRP1B | Ssm | 64 | 231 | 27.7% | cbioportal |
| 102 | USH2A | Ssm | 61 | 231 | 26.4% | cbioportal |
| 119 | CSMD1 | Ssm | 54 | 231 | 23.4% | cbioportal |
| 125 | FSIP2 | Ssm | 52 | 231 | 22.5% | cbioportal |
| 144 | EYS | Ssm | 45 | 231 | 19.5% | cbioportal |
| 153 | ZNF536 | Ssm | 43 | 231 | 18.6% | cbioportal |
| 152 | ZFHX4 | Ssm | 43 | 231 | 18.6% | cbioportal |
| 149 | PCDH15 | Ssm | 43 | 231 | 18.6% | cbioportal |
| 150 | SPTA1 | Ssm | 43 | 231 | 18.6% | cbioportal |
| 154 | ABCA13 | Ssm | 42 | 231 | 18.2% | cbioportal |
| 164 | CACNA1E | Ssm | 41 | 231 | 17.7% | cbioportal |
| 168 | XIRP2 | Ssm | 41 | 231 | 17.7% | cbioportal |
| 4 | STK11 | Ssm | 450 | 2,653 | 17% | cbioportal |
| 183 | FAT3 | Ssm | 38 | 231 | 16.5% | cbioportal |
| 182 | ASXL3 | Ssm | 38 | 231 | 16.5% | cbioportal |
| 186 | RYR1 | Ssm | 38 | 231 | 16.5% | cbioportal |
| 191 | MUC17 | Ssm | 37 | 231 | 16% | cbioportal |
| 189 | COL11A1 | Ssm | 37 | 231 | 16% | cbioportal |
| 198 | PAPPA2 | Ssm | 36 | 231 | 15.6% | cbioportal |
| 200 | ANK2 | Ssm | 35 | 231 | 15.2% | cbioportal |
| 5 | KEAP1 | Ssm | 400 | 2,653 | 15.1% | cbioportal |
| 6 | RBM10 | Ssm | 294 | 2,653 | 11.1% | cbioportal |
| 7 | PTPRD | Ssm | 270 | 2,653 | 10.2% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
186 cases with simple somatic mutation data · 186 cases total · 2026-04-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | EGFR | Ssm | 183 | 186 | 98.4% | cbioportal |
| 2 | TP53 | Ssm | 128 | 186 | 68.8% | cbioportal |
| 3 | PIK3CA | Ssm | 20 | 186 | 10.8% | cbioportal |
| 4 | RB1 | Ssm | 19 | 186 | 10.2% | cbioportal |
| 5 | CTNNB1 | Ssm | 18 | 186 | 9.7% | cbioportal |
| 6 | RBM10 | Ssm | 14 | 186 | 7.5% | cbioportal |
| 7 | PTEN | Ssm | 13 | 186 | 7% | cbioportal |
| 8 | ARID1A | Ssm | 10 | 186 | 5.4% | cbioportal |
| 10 | PTPRD | Ssm | 9 | 186 | 4.8% | cbioportal |
| 9 | ATR | Ssm | 9 | 186 | 4.8% | cbioportal |
| 13 | ZFHX3 | Ssm | 8 | 185 | 4.3% | cbioportal |
| 11 | APC | Ssm | 8 | 186 | 4.3% | cbioportal |
| 12 | KMT2C | Ssm | 8 | 186 | 4.3% | cbioportal |
| 14 | SMARCA4 | Ssm | 7 | 186 | 3.8% | cbioportal |
| 16 | FAT1 | Ssm | 6 | 186 | 3.2% | cbioportal |
| 18 | TSC2 | Ssm | 6 | 186 | 3.2% | cbioportal |
| 17 | NOTCH4 | Ssm | 6 | 186 | 3.2% | cbioportal |
| 15 | ASXL1 | Ssm | 6 | 186 | 3.2% | cbioportal |
| 27 | PLCG2 | Ssm | 5 | 185 | 2.7% | cbioportal |
| 23 | MGA | Ssm | 5 | 185 | 2.7% | cbioportal |
| 24 | MTOR | Ssm | 5 | 186 | 2.7% | cbioportal |
| 22 | MED12 | Ssm | 5 | 186 | 2.7% | cbioportal |
| 25 | NBN | Ssm | 5 | 186 | 2.7% | cbioportal |
| 26 | NOTCH2 | Ssm | 5 | 186 | 2.7% | cbioportal |
| 19 | EPHA5 | Ssm | 5 | 186 | 2.7% | cbioportal |
| 21 | KEAP1 | Ssm | 5 | 186 | 2.7% | cbioportal |
| 20 | H1-2 | Ssm | 5 | 186 | 2.7% | cbioportal |
| 28 | PTPRT | Ssm | 5 | 186 | 2.7% | cbioportal |
| 29 | TET1 | Ssm | 5 | 186 | 2.7% | cbioportal |
| 35 | CSF3R | Ssm | 4 | 185 | 2.2% | cbioportal |
Data updated 22 days agoSource updated 2026-04-07
604 cases with simple somatic mutation data · 604 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | KRAS | Ssm | 230 | 604 | 38.1% | cbioportal |
| 2 | TP53 | Ssm | 219 | 604 | 36.3% | cbioportal |
| 3 | EGFR | Ssm | 182 | 604 | 30.1% | cbioportal |
| 4 | RBM10 | Ssm | 97 | 604 | 16.1% | cbioportal |
| 5 | STK11 | Ssm | 90 | 604 | 14.9% | cbioportal |
| 6 | KEAP1 | Ssm | 68 | 604 | 11.3% | cbioportal |
| 7 | NF1 | Ssm | 48 | 604 | 7.9% | cbioportal |
| 8 | FAT1 | Ssm | 47 | 604 | 7.8% | cbioportal |
| 10 | PTPRT | Ssm | 47 | 604 | 7.8% | cbioportal |
| 9 | PTPRD | Ssm | 47 | 604 | 7.8% | cbioportal |
| 11 | ATM | Ssm | 44 | 604 | 7.3% | cbioportal |
| 12 | SETD2 | Ssm | 43 | 604 | 7.1% | cbioportal |
| 13 | BRAF | Ssm | 41 | 604 | 6.8% | cbioportal |
| 14 | MED12 | Ssm | 39 | 604 | 6.5% | cbioportal |
| 15 | EPHA3 | Ssm | 38 | 604 | 6.3% | cbioportal |
| 16 | PIK3CA | Ssm | 35 | 604 | 5.8% | cbioportal |
| 17 | MET | Ssm | 34 | 604 | 5.6% | cbioportal |
| 18 | NTRK3 | Ssm | 34 | 604 | 5.6% | cbioportal |
| 19 | MGA | Ssm | 33 | 596 | 5.5% | cbioportal |
| 20 | SMARCA4 | Ssm | 33 | 604 | 5.5% | cbioportal |
| 22 | ATRX | Ssm | 30 | 604 | 5% | cbioportal |
| 23 | EPHA5 | Ssm | 30 | 604 | 5% | cbioportal |
| 21 | ARID2 | Ssm | 30 | 604 | 5% | cbioportal |
| 24 | ERBB4 | Ssm | 29 | 604 | 4.8% | cbioportal |
| 25 | KMT2D | Ssm | 28 | 604 | 4.6% | cbioportal |
| 29 | TERT | Ssm | 27 | 604 | 4.5% | cbioportal |
| 27 | ERBB2 | Ssm | 27 | 604 | 4.5% | cbioportal |
| 28 | GRIN2A | Ssm | 27 | 604 | 4.5% | cbioportal |
| 26 | CDKN2A | Ssm | 27 | 604 | 4.5% | cbioportal |
| 31 | MTOR | Ssm | 26 | 604 | 4.3% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
426 cases with simple somatic mutation data · 426 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 155 | 426 | 36.4% | cbioportal |
| 2 | KRAS | Ssm | 147 | 426 | 34.5% | cbioportal |
| 3 | EGFR | Ssm | 139 | 426 | 32.6% | cbioportal |
| 4 | RBM10 | Ssm | 81 | 426 | 19% | cbioportal |
| 5 | STK11 | Ssm | 66 | 426 | 15.5% | cbioportal |
| 6 | KEAP1 | Ssm | 46 | 426 | 10.8% | cbioportal |
| 7 | FAT1 | Ssm | 36 | 426 | 8.5% | cbioportal |
| 8 | NF1 | Ssm | 35 | 426 | 8.2% | cbioportal |
| 9 | PTPRD | Ssm | 34 | 426 | 8% | cbioportal |
| 10 | SETD2 | Ssm | 34 | 426 | 8% | cbioportal |
| 11 | PTPRT | Ssm | 32 | 426 | 7.5% | cbioportal |
| 12 | ATM | Ssm | 30 | 426 | 7% | cbioportal |
| 14 | SMARCA4 | Ssm | 29 | 426 | 6.8% | cbioportal |
| 13 | BRAF | Ssm | 29 | 426 | 6.8% | cbioportal |
| 16 | MED12 | Ssm | 28 | 426 | 6.6% | cbioportal |
| 15 | KMT2D | Ssm | 28 | 426 | 6.6% | cbioportal |
| 21 | MGA | Ssm | 24 | 418 | 5.7% | cbioportal |
| 17 | EPHA3 | Ssm | 24 | 426 | 5.6% | cbioportal |
| 20 | MET | Ssm | 24 | 426 | 5.6% | cbioportal |
| 22 | NTRK3 | Ssm | 24 | 426 | 5.6% | cbioportal |
| 19 | KMT2C | Ssm | 24 | 426 | 5.6% | cbioportal |
| 18 | GRIN2A | Ssm | 24 | 426 | 5.6% | cbioportal |
| 23 | ARID2 | Ssm | 23 | 426 | 5.4% | cbioportal |
| 26 | PIK3C2G | Ssm | 22 | 426 | 5.2% | cbioportal |
| 24 | EPHA5 | Ssm | 22 | 426 | 5.2% | cbioportal |
| 25 | ERBB4 | Ssm | 22 | 426 | 5.2% | cbioportal |
| 27 | PIK3CA | Ssm | 22 | 426 | 5.2% | cbioportal |
| 29 | NOTCH4 | Ssm | 21 | 426 | 4.9% | cbioportal |
| 28 | FLT1 | Ssm | 21 | 426 | 4.9% | cbioportal |
| 30 | TERT | Ssm | 20 | 426 | 4.7% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
35 cases with simple somatic mutation data · 35 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | MUC4 | Ssm | 19 | 35 | 54.3% | cbioportal |
| 2 | TP53 | Ssm | 16 | 35 | 45.7% | cbioportal |
| 3 | MUC16 | Ssm | 13 | 35 | 37.1% | cbioportal |
| 4 | CSMD3 | Ssm | 11 | 35 | 31.4% | cbioportal |
| 6 | TTN | Ssm | 11 | 35 | 31.4% | cbioportal |
| 5 | LRP1B | Ssm | 11 | 35 | 31.4% | cbioportal |
| 10 | ZFHX4 | Ssm | 10 | 35 | 28.6% | cbioportal |
| 9 | RYR2 | Ssm | 10 | 35 | 28.6% | cbioportal |
| 8 | OBSCN | Ssm | 10 | 35 | 28.6% | cbioportal |
| 7 | HRNR | Ssm | 10 | 35 | 28.6% | cbioportal |
| 13 | TNRC18 | Ssm | 9 | 35 | 25.7% | cbioportal |
| 12 | FLNC | Ssm | 9 | 35 | 25.7% | cbioportal |
| 11 | FLG | Ssm | 9 | 35 | 25.7% | cbioportal |
| 15 | KRAS | Ssm | 8 | 35 | 22.9% | cbioportal |
| 14 | CROCC | Ssm | 8 | 35 | 22.9% | cbioportal |
| 20 | PCDH15 | Ssm | 7 | 35 | 20% | cbioportal |
| 18 | CSMD1 | Ssm | 7 | 35 | 20% | cbioportal |
| 17 | CRB2 | Ssm | 7 | 35 | 20% | cbioportal |
| 16 | CACNA1A | Ssm | 7 | 35 | 20% | cbioportal |
| 19 | MUC5B | Ssm | 7 | 35 | 20% | cbioportal |
| 21 | ANK2 | Ssm | 6 | 35 | 17.1% | cbioportal |
| 29 | MUC17 | Ssm | 6 | 35 | 17.1% | cbioportal |
| 28 | MROH2B | Ssm | 6 | 35 | 17.1% | cbioportal |
| 27 | JAG2 | Ssm | 6 | 35 | 17.1% | cbioportal |
| 26 | FBN2 | Ssm | 6 | 35 | 17.1% | cbioportal |
| 25 | DNAH11 | Ssm | 6 | 35 | 17.1% | cbioportal |
| 24 | CSMD2 | Ssm | 6 | 35 | 17.1% | cbioportal |
| 23 | CDH10 | Ssm | 6 | 35 | 17.1% | cbioportal |
| 22 | APOB | Ssm | 6 | 35 | 17.1% | cbioportal |
| 30 | NPHP4 | Ssm | 6 | 35 | 17.1% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
302 cases with simple somatic mutation data · 305 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | EGFR | Ssm | 143 | 302 | 47.4% | cbioportal |
| 2 | TP53 | Ssm | 109 | 302 | 36.1% | cbioportal |
| 3 | TTN | Ssm | 68 | 302 | 22.5% | cbioportal |
| 4 | RYR2 | Ssm | 50 | 302 | 16.6% | cbioportal |
| 5 | USH2A | Ssm | 50 | 302 | 16.6% | cbioportal |
| 6 | MUC16 | Ssm | 46 | 302 | 15.2% | cbioportal |
| 7 | CSMD3 | Ssm | 43 | 302 | 14.2% | cbioportal |
| 8 | ZFHX4 | Ssm | 39 | 302 | 12.9% | cbioportal |
| 9 | FLG | Ssm | 37 | 302 | 12.3% | cbioportal |
| 10 | LRP1B | Ssm | 35 | 302 | 11.6% | cbioportal |
| 11 | KRAS | Ssm | 33 | 302 | 10.9% | cbioportal |
| 12 | PCLO | Ssm | 30 | 302 | 9.9% | cbioportal |
| 13 | SPTA1 | Ssm | 30 | 302 | 9.9% | cbioportal |
| 14 | XIRP2 | Ssm | 30 | 302 | 9.9% | cbioportal |
| 15 | ANK2 | Ssm | 29 | 302 | 9.6% | cbioportal |
| 16 | SI | Ssm | 27 | 302 | 8.9% | cbioportal |
| 17 | CTNND2 | Ssm | 26 | 302 | 8.6% | cbioportal |
| 18 | FAT3 | Ssm | 26 | 302 | 8.6% | cbioportal |
| 19 | MUC17 | Ssm | 26 | 302 | 8.6% | cbioportal |
| 20 | AHNAK2 | Ssm | 24 | 302 | 7.9% | cbioportal |
| 21 | COL11A1 | Ssm | 24 | 302 | 7.9% | cbioportal |
| 22 | CSMD1 | Ssm | 24 | 302 | 7.9% | cbioportal |
| 23 | FAT4 | Ssm | 24 | 302 | 7.9% | cbioportal |
| 24 | PRDM9 | Ssm | 24 | 302 | 7.9% | cbioportal |
| 25 | MUC4 | Ssm | 23 | 302 | 7.6% | cbioportal |
| 26 | NAV3 | Ssm | 23 | 302 | 7.6% | cbioportal |
| 27 | NEB | Ssm | 23 | 302 | 7.6% | cbioportal |
| 28 | ZNF536 | Ssm | 23 | 302 | 7.6% | cbioportal |
| 29 | RBM10 | Ssm | 22 | 302 | 7.3% | cbioportal |
| 30 | ADAMTS12 | Ssm | 21 | 302 | 7% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
230 cases with simple somatic mutation data · 586 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TTN | Ssm | 108 | 230 | 47% | cbioportal |
| 2 | TP53 | Ssm | 106 | 230 | 46.1% | cbioportal |
| 3 | MUC16 | Ssm | 91 | 230 | 39.6% | cbioportal |
| 4 | RYR2 | Ssm | 82 | 230 | 35.7% | cbioportal |
| 5 | KRAS | Ssm | 75 | 230 | 32.6% | cbioportal |
| 6 | LRP1B | Ssm | 68 | 230 | 29.6% | cbioportal |
| 7 | USH2A | Ssm | 68 | 230 | 29.6% | cbioportal |
| 8 | ZFHX4 | Ssm | 63 | 230 | 27.4% | cbioportal |
| 9 | FLG | Ssm | 62 | 230 | 27% | cbioportal |
| 10 | SPTA1 | Ssm | 58 | 230 | 25.2% | cbioportal |
| 11 | MUC17 | Ssm | 48 | 230 | 20.9% | cbioportal |
| 12 | XIRP2 | Ssm | 47 | 230 | 20.4% | cbioportal |
| 13 | PCLO | Ssm | 46 | 230 | 20% | cbioportal |
| 14 | NAV3 | Ssm | 45 | 230 | 19.6% | cbioportal |
| 15 | CSMD1 | Ssm | 44 | 230 | 19.1% | cbioportal |
| 16 | FAT3 | Ssm | 44 | 230 | 19.1% | cbioportal |
| 17 | KMT2C | Ssm | 42 | 230 | 18.3% | cbioportal |
| 18 | PCDH15 | Ssm | 42 | 230 | 18.3% | cbioportal |
| 19 | ZNF536 | Ssm | 42 | 230 | 18.3% | cbioportal |
| 20 | COL11A1 | Ssm | 40 | 230 | 17.4% | cbioportal |
| 21 | KEAP1 | Ssm | 40 | 230 | 17.4% | cbioportal |
| 22 | STK11 | Ssm | 40 | 230 | 17.4% | cbioportal |
| 23 | ADGRG4 | Ssm | 39 | 230 | 17% | cbioportal |
| 24 | PAPPA2 | Ssm | 39 | 230 | 17% | cbioportal |
| 25 | RP1L1 | Ssm | 39 | 230 | 17% | cbioportal |
| 26 | ADAMTS12 | Ssm | 38 | 230 | 16.5% | cbioportal |
| 27 | AHNAK2 | Ssm | 38 | 230 | 16.5% | cbioportal |
| 28 | APOB | Ssm | 38 | 230 | 16.5% | cbioportal |
| 29 | ZNF804A | Ssm | 38 | 230 | 16.5% | cbioportal |
| 30 | DNAH9 | Ssm | 37 | 230 | 16.1% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
559 cases with simple somatic mutation data · 571 cases total · 2026-01-13 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 284 | 559 | 50.8% | cbioportal |
| 2 | TTN | Ssm | 245 | 559 | 43.8% | cbioportal |
| 3 | MUC16 | Ssm | 225 | 559 | 40.3% | cbioportal |
| 4 | CSMD3 | Ssm | 213 | 559 | 38.1% | cbioportal |
| 5 | RYR2 | Ssm | 200 | 559 | 35.8% | cbioportal |
| 6 | LRP1B | Ssm | 184 | 559 | 32.9% | cbioportal |
| 7 | ZFHX4 | Ssm | 172 | 559 | 30.8% | cbioportal |
| 8 | USH2A | Ssm | 168 | 559 | 30.1% | cbioportal |
| 9 | KRAS | Ssm | 149 | 559 | 26.7% | cbioportal |
| 10 | XIRP2 | Ssm | 134 | 559 | 24% | cbioportal |
| 11 | FLG | Ssm | 129 | 559 | 23.1% | cbioportal |
| 12 | SPTA1 | Ssm | 124 | 559 | 22.2% | cbioportal |
| 13 | NAV3 | Ssm | 117 | 559 | 20.9% | cbioportal |
| 14 | COL11A1 | Ssm | 114 | 559 | 20.4% | cbioportal |
| 15 | ZNF536 | Ssm | 112 | 559 | 20% | cbioportal |
| 16 | FAT3 | Ssm | 107 | 559 | 19.1% | cbioportal |
| 17 | ANK2 | Ssm | 106 | 559 | 19% | cbioportal |
| 18 | CSMD1 | Ssm | 103 | 559 | 18.4% | cbioportal |
| 19 | PCLO | Ssm | 103 | 559 | 18.4% | cbioportal |
| 20 | APOB | Ssm | 101 | 559 | 18.1% | cbioportal |
| 21 | PCDH15 | Ssm | 101 | 559 | 18.1% | cbioportal |
| 22 | KEAP1 | Ssm | 98 | 559 | 17.5% | cbioportal |
| 23 | ADAMTS12 | Ssm | 97 | 559 | 17.4% | cbioportal |
| 24 | MUC17 | Ssm | 97 | 559 | 17.4% | cbioportal |
| 25 | TNR | Ssm | 95 | 559 | 17% | cbioportal |
| 26 | DNAH9 | Ssm | 93 | 559 | 16.6% | cbioportal |
| 27 | PAPPA2 | Ssm | 90 | 559 | 16.1% | cbioportal |
| 28 | RP1L1 | Ssm | 90 | 559 | 16.1% | cbioportal |
| 29 | ADGRG4 | Ssm | 89 | 559 | 15.9% | cbioportal |
| 30 | RYR3 | Ssm | 89 | 559 | 15.9% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
230 cases with simple somatic mutation data · 230 cases total · 2026-01-19 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TTN | Ssm | 108 | 230 | 47% | cbioportal |
| 2 | TP53 | Ssm | 107 | 230 | 46.5% | cbioportal |
| 3 | MUC16 | Ssm | 91 | 230 | 39.6% | cbioportal |
| 4 | RYR2 | Ssm | 82 | 230 | 35.7% | cbioportal |
| 5 | CSMD3 | Ssm | 81 | 230 | 35.2% | cbioportal |
| 6 | KRAS | Ssm | 75 | 230 | 32.6% | cbioportal |
| 7 | LRP1B | Ssm | 68 | 230 | 29.6% | cbioportal |
| 8 | USH2A | Ssm | 68 | 230 | 29.6% | cbioportal |
| 9 | ZFHX4 | Ssm | 63 | 230 | 27.4% | cbioportal |
| 10 | FLG | Ssm | 62 | 230 | 27% | cbioportal |
| 11 | SPTA1 | Ssm | 58 | 230 | 25.2% | cbioportal |
| 12 | MUC17 | Ssm | 48 | 230 | 20.9% | cbioportal |
| 13 | XIRP2 | Ssm | 47 | 230 | 20.4% | cbioportal |
| 14 | PCLO | Ssm | 46 | 230 | 20% | cbioportal |
| 15 | NAV3 | Ssm | 45 | 230 | 19.6% | cbioportal |
| 17 | FAT3 | Ssm | 44 | 230 | 19.1% | cbioportal |
| 16 | CSMD1 | Ssm | 44 | 230 | 19.1% | cbioportal |
| 18 | KMT2C | Ssm | 43 | 230 | 18.7% | cbioportal |
| 20 | ZNF536 | Ssm | 42 | 230 | 18.3% | cbioportal |
| 19 | PCDH15 | Ssm | 42 | 230 | 18.3% | cbioportal |
| 21 | COL11A1 | Ssm | 40 | 230 | 17.4% | cbioportal |
| 23 | STK11 | Ssm | 40 | 230 | 17.4% | cbioportal |
| 22 | KEAP1 | Ssm | 40 | 230 | 17.4% | cbioportal |
| 26 | RP1L1 | Ssm | 39 | 230 | 17% | cbioportal |
| 25 | PAPPA2 | Ssm | 39 | 230 | 17% | cbioportal |
| 24 | ADGRG4 | Ssm | 39 | 230 | 17% | cbioportal |
| 29 | APOB | Ssm | 38 | 230 | 16.5% | cbioportal |
| 28 | AHNAK2 | Ssm | 38 | 230 | 16.5% | cbioportal |
| 27 | ADAMTS12 | Ssm | 38 | 230 | 16.5% | cbioportal |
| 30 | ZNF804A | Ssm | 38 | 230 | 16.5% | cbioportal |
Data updated 22 days agoSource updated 2026-01-19
566 cases with simple somatic mutation data · 566 cases total · 2026-06-04 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 295 | 566 | 52.1% | cbioportal |
| 2 | TTN | Ssm | 272 | 566 | 48.1% | cbioportal |
| 3 | MUC16 | Ssm | 242 | 566 | 42.8% | cbioportal |
| 4 | CSMD3 | Ssm | 226 | 566 | 39.9% | cbioportal |
| 5 | RYR2 | Ssm | 217 | 566 | 38.3% | cbioportal |
| 6 | LRP1B | Ssm | 201 | 566 | 35.5% | cbioportal |
| 7 | ZFHX4 | Ssm | 185 | 566 | 32.7% | cbioportal |
| 8 | USH2A | Ssm | 177 | 566 | 31.3% | cbioportal |
| 9 | KRAS | Ssm | 168 | 566 | 29.7% | cbioportal |
| 10 | XIRP2 | Ssm | 150 | 566 | 26.5% | cbioportal |
| 11 | SPTA1 | Ssm | 148 | 566 | 26.1% | cbioportal |
| 12 | FLG | Ssm | 145 | 566 | 25.6% | cbioportal |
| 13 | CSMD1 | Ssm | 125 | 566 | 22.1% | cbioportal |
| 14 | NAV3 | Ssm | 123 | 566 | 21.7% | cbioportal |
| 15 | FAT3 | Ssm | 121 | 566 | 21.4% | cbioportal |
| 16 | COL11A1 | Ssm | 120 | 566 | 21.2% | cbioportal |
| 17 | PCDH15 | Ssm | 118 | 566 | 20.8% | cbioportal |
| 18 | ZNF536 | Ssm | 117 | 566 | 20.7% | cbioportal |
| 19 | ANK2 | Ssm | 111 | 566 | 19.6% | cbioportal |
| 20 | MUC17 | Ssm | 111 | 566 | 19.6% | cbioportal |
| 21 | PCLO | Ssm | 109 | 566 | 19.3% | cbioportal |
| 22 | RYR3 | Ssm | 106 | 566 | 18.7% | cbioportal |
| 23 | APOB | Ssm | 104 | 566 | 18.4% | cbioportal |
| 24 | KEAP1 | Ssm | 102 | 566 | 18% | cbioportal |
| 25 | PAPPA2 | Ssm | 101 | 566 | 17.8% | cbioportal |
| 26 | ADAMTS12 | Ssm | 99 | 566 | 17.5% | cbioportal |
| 27 | DNAH9 | Ssm | 99 | 566 | 17.5% | cbioportal |
| 28 | ADGRG4 | Ssm | 98 | 566 | 17.3% | cbioportal |
| 29 | RP1L1 | Ssm | 97 | 566 | 17.1% | cbioportal |
| 30 | RYR1 | Ssm | 95 | 566 | 16.8% | cbioportal |
Data updated 22 days agoSource updated 2026-06-04
163 cases with simple somatic mutation data · 163 cases total · 2026-01-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 64 | 163 | 39.3% | cbioportal |
| 2 | KRAS | Ssm | 60 | 163 | 36.8% | cbioportal |
| 3 | STK11 | Ssm | 34 | 163 | 20.9% | cbioportal |
| 4 | EGFR | Ssm | 30 | 163 | 18.4% | cbioportal |
| 5 | LRP1B | Ssm | 16 | 163 | 9.8% | cbioportal |
| 6 | ATM | Ssm | 13 | 163 | 8% | cbioportal |
| 7 | NF1 | Ssm | 13 | 163 | 8% | cbioportal |
| 8 | APC | Ssm | 11 | 163 | 6.7% | cbioportal |
| 9 | EPHA3 | Ssm | 10 | 163 | 6.1% | cbioportal |
| 10 | CDKN2A | Ssm | 9 | 163 | 5.5% | cbioportal |
| 11 | PTPRD | Ssm | 9 | 163 | 5.5% | cbioportal |
| 12 | ERBB4 | Ssm | 8 | 163 | 4.9% | cbioportal |
| 13 | KDR | Ssm | 8 | 163 | 4.9% | cbioportal |
| 14 | EPHA5 | Ssm | 7 | 163 | 4.3% | cbioportal |
| 15 | FGFR4 | Ssm | 7 | 163 | 4.3% | cbioportal |
| 16 | MYO3B | Ssm | 7 | 163 | 4.3% | cbioportal |
| 17 | NTRK1 | Ssm | 7 | 163 | 4.3% | cbioportal |
| 18 | NTRK3 | Ssm | 7 | 163 | 4.3% | cbioportal |
| 19 | PRKDC | Ssm | 7 | 163 | 4.3% | cbioportal |
| 20 | RB1 | Ssm | 7 | 163 | 4.3% | cbioportal |
| 23 | LTK | Ssm | 6 | 163 | 3.7% | cbioportal |
| 21 | EPHA7 | Ssm | 6 | 163 | 3.7% | cbioportal |
| 22 | INSRR | Ssm | 6 | 163 | 3.7% | cbioportal |
| 24 | NTRK2 | Ssm | 6 | 163 | 3.7% | cbioportal |
| 25 | PDGFRA | Ssm | 6 | 163 | 3.7% | cbioportal |
| 26 | CDC42BPA | Ssm | 5 | 163 | 3.1% | cbioportal |
| 27 | DOCK3 | Ssm | 5 | 163 | 3.1% | cbioportal |
| 28 | EPHB6 | Ssm | 5 | 163 | 3.1% | cbioportal |
| 29 | INHBA | Ssm | 5 | 163 | 3.1% | cbioportal |
| 30 | JAK2 | Ssm | 5 | 163 | 3.1% | cbioportal |
Data updated 22 days agoSource updated 2026-01-07
232 cases with simple somatic mutation data · 232 cases total · 2026-01-16 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | EGFR | Ssm | 66 | 232 | 28.4% | cbioportal |
| 2 | TP53 | Ssm | 36 | 232 | 15.5% | cbioportal |
| 3 | TTN | Ssm | 21 | 232 | 9.1% | cbioportal |
| 4 | KRAS | Ssm | 17 | 232 | 7.3% | cbioportal |
| 5 | RBM10 | Ssm | 17 | 232 | 7.3% | cbioportal |
| 6 | MUC16 | Ssm | 12 | 232 | 5.2% | cbioportal |
| 7 | LRRK2 | Ssm | 10 | 232 | 4.3% | cbioportal |
| 9 | SETD2 | Ssm | 10 | 232 | 4.3% | cbioportal |
| 8 | PIK3CA | Ssm | 10 | 232 | 4.3% | cbioportal |
| 14 | UBA1 | Ssm | 9 | 232 | 3.9% | cbioportal |
| 13 | RYR2 | Ssm | 9 | 232 | 3.9% | cbioportal |
| 12 | REV3L | Ssm | 9 | 232 | 3.9% | cbioportal |
| 11 | HUWE1 | Ssm | 9 | 232 | 3.9% | cbioportal |
| 10 | ERBB2 | Ssm | 9 | 232 | 3.9% | cbioportal |
| 16 | ZFHX4 | Ssm | 9 | 232 | 3.9% | cbioportal |
| 15 | XIRP2 | Ssm | 9 | 232 | 3.9% | cbioportal |
| 18 | CSMD1 | Ssm | 8 | 232 | 3.4% | cbioportal |
| 17 | BIRC6 | Ssm | 8 | 232 | 3.4% | cbioportal |
| 20 | LRP1B | Ssm | 8 | 232 | 3.4% | cbioportal |
| 19 | CSMD3 | Ssm | 8 | 232 | 3.4% | cbioportal |
| 26 | FSIP2 | Ssm | 7 | 232 | 3% | cbioportal |
| 24 | DNAH5 | Ssm | 7 | 232 | 3% | cbioportal |
| 23 | ARID2 | Ssm | 7 | 232 | 3% | cbioportal |
| 22 | ARID1A | Ssm | 7 | 232 | 3% | cbioportal |
| 21 | AR | Ssm | 7 | 232 | 3% | cbioportal |
| 28 | MET | Ssm | 7 | 232 | 3% | cbioportal |
| 27 | GLUD2 | Ssm | 7 | 232 | 3% | cbioportal |
| 25 | FBN2 | Ssm | 7 | 232 | 3% | cbioportal |
| 30 | ADGRV1 | Ssm | 6 | 232 | 2.6% | cbioportal |
| 29 | ADGRG4 | Ssm | 6 | 232 | 2.6% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
915 cases with simple somatic mutation data · 915 cases total · 2026-04-07 · mapped to Lung Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 485 | 915 | 53% | cbioportal |
| 2 | EGFR | Ssm | 268 | 915 | 29.3% | cbioportal |
| 3 | KRAS | Ssm | 241 | 915 | 26.3% | cbioportal |
| 4 | STK11 | Ssm | 157 | 915 | 17.2% | cbioportal |
| 5 | KEAP1 | Ssm | 153 | 915 | 16.7% | cbioportal |
| 6 | SMARCA4 | Ssm | 92 | 915 | 10.1% | cbioportal |
| 7 | PTPRD | Ssm | 89 | 915 | 9.7% | cbioportal |
| 8 | RBM10 | Ssm | 78 | 915 | 8.5% | cbioportal |
| 9 | FAT1 | Ssm | 71 | 915 | 7.8% | cbioportal |
| 10 | ARID1A | Ssm | 69 | 915 | 7.5% | cbioportal |
| 11 | NF1 | Ssm | 67 | 915 | 7.3% | cbioportal |
| 12 | PTPRT | Ssm | 67 | 915 | 7.3% | cbioportal |
| 14 | PIK3CA | Ssm | 65 | 915 | 7.1% | cbioportal |
| 13 | ATM | Ssm | 65 | 915 | 7.1% | cbioportal |
| 15 | EPHA3 | Ssm | 59 | 915 | 6.4% | cbioportal |
| 16 | KMT2D | Ssm | 58 | 915 | 6.3% | cbioportal |
| 17 | HGF | Ssm | 56 | 915 | 6.1% | cbioportal |
| 18 | SETD2 | Ssm | 56 | 915 | 6.1% | cbioportal |
| 19 | KMT2C | Ssm | 53 | 915 | 5.8% | cbioportal |
| 20 | ATRX | Ssm | 52 | 915 | 5.7% | cbioportal |
| 21 | BRAF | Ssm | 50 | 915 | 5.5% | cbioportal |
| 22 | EPHA5 | Ssm | 50 | 915 | 5.5% | cbioportal |
| 23 | RB1 | Ssm | 50 | 915 | 5.5% | cbioportal |
| 42 | ZFHX3 | Ssm | 34 | 623 | 5.5% | cbioportal |
| 24 | APC | Ssm | 49 | 915 | 5.4% | cbioportal |
| 25 | CDKN2A | Ssm | 49 | 915 | 5.4% | cbioportal |
| 50 | EPHA7 | Ssm | 31 | 623 | 5% | cbioportal |
| 26 | ARID2 | Ssm | 45 | 915 | 4.9% | cbioportal |
| 27 | NTRK3 | Ssm | 44 | 915 | 4.8% | cbioportal |
| 55 | MGA | Ssm | 29 | 623 | 4.7% | cbioportal |
Data updated 22 days agoSource updated 2026-04-07